Sfoglia per Autore
Clinical outcome of HBeAg-negative chronic hepatitis B in relation to virological response to lamivudine
2004 V. Di Marco, A. Marzano, P. Lampertico, P. Andreone, T. Santantonio, P.L. Almasio, M. Rizzetto, A. Craxì, G. Raimondo, G. Squadrito, A. Spadaro, O. Ferrah, T. Santantonio, G. Pastore, G. Niro, A. Andriulli, G. Stornaiolo, M. Stanzione, G.B. Gaeta, F. Piccinino, A. Marrone, G. Ruggiero, R. Ganga, M. Bernas coni, G. Pilleri, M. Brunetto, B. Coco, F. Bonino, G. Mazzella, F. Lodato, P. Andreone, C. Cursaro, s. Fiorino, A.G. Gramenzi, M. Massari, F. Torre, M. Basso, A. Picciotto, S. Targhetta, P. Burra, V. Ciappina, E. Mazzeffini, R. Bruno, S. Bruno, M. Vigano, M. Iavarone, E. Del Ninno, M. Colombo, A. Casella, M. Sonzogni, G. Colloredo, S. Rossi, M. Puoti, S. Gaia, V. Barbon, M. Lagget
Prophylaxis of hepatitis B virus recurrence after liver transplantation in carriers of lamivudine-resistant mutants
2005 A. Marzano, P. Lampertico, V. Mazzaferro, S. Saia, M. Viganò, R. Romito, A. Pulvirenti, A. Franchello, M. Colombo, M. Salizzoni, M. Rizzetto
Inhibition of HBV-replication by combined treatment of lamivudine and adefovir dipivoxil allows long-term campath-1H therapy in refractory B-cell chronic lymphoblastic leukemia
2005 A. Cortelezzi, M. Viganò, V.R. Zilioli, N.N. Fantini, M.C. Pasquini, M. Colombo, G. Lambertenghi Deliliers, P. Lampertico
Five years of sequential lam to lam_adv therapy suppresses HBV replication in most hbeag-negative cirrhotics, preventing decompensation but not hepatocellular carcinoma
2005 P. Lampertico, M. Vigano, E. Manenti, M.A. Iavarone, G. Lunghi, M. Colombo
Twenty-four months combination therapy with adefovir dipivoxil and lamivudine in lamivudine resistant patients with HBeAg-negative chronic hepatitis B
2005 P. Lampertico, M. Viganò, E. Manenti, G. Lunghi, M.A. Iavarone, E. Del Ninno, M. Colombo
Long-term lamivudine monotherapy in renal-transplant recipients with hepatitis-B-related cirrhosis
2005 M. Viganò, M. Colombo, A. Aroldi, G. Lunghi, E. Manenti, C. Ponticelli, P. Lampertico
Twenty-four months combination therapy with adefovir dipivoxil and lamivudine in lamivudine resistano patients with HBeAg-negative chronic hepatitis B
2005 P. Lampertico, M. Viganò, E. Manenti, G. Lunghi, M.A. Iavarone, E. Del Ninno, M. Colombo
Combined lamivudine and adefovir dipivoxil treatment allows safe and long-term compath-1H therapy in refractory B-cell chronic lymphocytic leukemia with HBV reactivation
2005 A. Cortelezzi, M. Viganò, V.R. Zilioli, N.N. Fantini, M.C. Pasquini, M. Colombo, G. Lambertenghi Deliliers, P. Lampertico
Versant 3.0 and Cobas Taqman for monitoring serum HBV-DNA in HBeAg-negative patients under lamivudine-adefovir combinant therapy
2005 P. Lampertico, M. Viganò, E. Manenti, G. Lunghi, M.A. Iavarone, G. Colucci, M. Colombo
US features of liver surface nodularity as a predictor of severe fibrosis in chronic hepatitis C
2005 M. Viganò, S. Visentin, A. Aghemo, M. G. Rumi, G. Ronchi, A. Colli, A. Colucci, S. Paggi, M. Fraquelli, D. Conte
Versant 3.0 and Cobas Taqman for monitoring serum HBV-DNA in HBeAg-negative patients under lamivudine-adefovir combinant therapy
2005 P. Lampertico, M. Viganò, E. Manenti, G. Lunghi, M.A. Iavarone, G. Colucci, M. Colombo
Adefovir rapidly suppresses hepatitis B in HBeAg-negative patients developing genotypic resistance to lamivudine
2005 P. Lampertico, M. Viganò, E. Manenti, M.A. Iavarone, G. Lunghi, M. Colombo
Evaluating liver fibrosis in chronic hepatitis c (CHC), accuracy of two new predictive models
2006 C. Facciotto, M. Fraquelli, D. Conte, M. Colombo, M. Viganò, S. Paggi, P. Dal Poggio, A. Colli
Protocol liver biopsies to evaluate severity of recurrent HCV hepatitis : a recent monocentric experience
2006 M.F. Donato, C. Rigamonti, F. Agnelli, G. Rossi, U. Maggi, M. Viganò, E. Arosio, M. Maggioni, M. Colombo, L.R. Fassati
Combination therapy with adefovir dipivoxil (ADV)and lamivudine (LAM) in LAM-resistant patients enlisted for liver transplantation
2006 M. Viganò, V. Mazzaferro, E. Manenti, R. Romito, G. Lunghi, A. Pulvirenti, M. Colombo, P. Lampertico
Severe hepatic fibrosis in chronic hepatitis C
2006 C. Facciotto, M. Fraquelli, D. Conte, M. Colombo, M. Vigano', S. Paggi, P. Dal Poggio, A. Colli
No evidence for ADV resistance in HBeAg-negative Lamivudine resistant patients treated with LAMIVUDINE-ADEFOVIR combination for 3 years
2006 M. Viganò, E. Manenti, E. Del Ninno, M. Colombo, P. Lampertico
Accuracy of two new predictive models in assessing fibrosis in chronic hepatitis C (CHC)
2006 S. Paggi, M. Fraquelli, D. Conte, M. Colombo, M. Viganò, C. Facciotto, P. Dal Poggio, A. Cossi
Hepatitis B virus reverse seroconversion in allogeneic hematopoietic stem cell transplantation
2006 M. Viganò, C. Vener, D. Soligo, M. Colombo, F. Lanfranchi, G. Lambertenghi Deliliers, P. Lampertico
Low rates of genotypic resistance to adefovir in lamivudine resistant patients treated with adefovir-lamivudine combination therapy for 3 years
2006 P. Lampertico, M. Viganò, M. Iavarone, E. Manenti, G. Lunghi, E. Del Ninno, M. Colombo
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile